Leerink Partnrs Issues Optimistic Outlook for ALGN Earnings

Align Technology, Inc. (NASDAQ:ALGN - Free Report) - Stock analysts at Leerink Partnrs upped their Q2 2025 earnings per share estimates for shares of Align Technology in a report issued on Monday, July 14th. Leerink Partnrs analyst M. Cherny now expects that the medical equipment provider will earn $2.10 per share for the quarter, up from their previous forecast of $2.07. The consensus estimate for Align Technology's current full-year earnings is $7.98 per share. Leerink Partnrs also issued estimates for Align Technology's Q3 2025 earnings at $2.28 EPS, Q4 2025 earnings at $2.40 EPS, FY2025 earnings at $8.43 EPS, FY2026 earnings at $9.33 EPS, FY2027 earnings at $10.67 EPS and FY2028 earnings at $11.85 EPS.

Align Technology (NASDAQ:ALGN - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The medical equipment provider reported $2.13 EPS for the quarter, beating the consensus estimate of $2.00 by $0.13. Align Technology had a net margin of 10.29% and a return on equity of 13.52%. The company had revenue of $979.26 million for the quarter, compared to analyst estimates of $977.90 million. During the same period in the prior year, the company earned $2.14 earnings per share. The firm's revenue was down 1.8% on a year-over-year basis.

A number of other brokerages have also weighed in on ALGN. HSBC lowered shares of Align Technology from a "buy" rating to a "hold" rating and decreased their price target for the company from $290.00 to $170.00 in a research note on Friday, April 25th. UBS Group decreased their price target on shares of Align Technology from $240.00 to $215.00 and set a "neutral" rating on the stock in a research note on Thursday, April 24th. Evercore ISI raised their price target on shares of Align Technology from $200.00 to $220.00 and gave the company an "outperform" rating in a research note on Wednesday, July 9th. Hsbc Global Res downgraded shares of Align Technology from a "strong-buy" rating to a "hold" rating in a report on Friday, April 25th. Finally, Piper Sandler reiterated an "overweight" rating and issued a $250.00 price objective (up previously from $235.00) on shares of Align Technology in a report on Thursday, May 1st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $242.92.

Align Technology Stock Down 0.8%

Shares of ALGN stock traded down $1.50 during mid-day trading on Thursday, hitting $190.77. 474,609 shares of the stock were exchanged, compared to its average volume of 922,320. The firm has a fifty day moving average of $186.00 and a 200 day moving average of $187.19. Align Technology has a 52-week low of $141.74 and a 52-week high of $262.87. The company has a market cap of $13.83 billion, a PE ratio of 34.75, a price-to-earnings-growth ratio of 2.02 and a beta of 1.63.

Institutional Trading of Align Technology

A number of large investors have recently modified their holdings of ALGN. GKV Capital Management Co. Inc. acquired a new position in Align Technology in the fourth quarter valued at $31,000. Compagnie Lombard Odier SCmA acquired a new stake in shares of Align Technology during the first quarter worth about $32,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of Align Technology during the fourth quarter worth about $35,000. Center for Financial Planning Inc. acquired a new stake in shares of Align Technology during the first quarter worth about $35,000. Finally, SVB Wealth LLC acquired a new stake in shares of Align Technology during the first quarter worth about $36,000. Hedge funds and other institutional investors own 88.43% of the company's stock.

Align Technology announced that its Board of Directors has authorized a stock repurchase program on Tuesday, May 6th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the medical equipment provider to buy up to 7.9% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's board believes its shares are undervalued.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.